Pharmaceutical, biotechnology and medical technologies corporation Johnson & Johnson (NYSE:JNJ) announced on Monday that it has submitted a supplemental Biologics License Application to the US FDA for DARZALEX FASPRO in combination with bortezomib, lenalidomide, and dexamethasone (D-VRd).
This application seeks approval for treating newly diagnosed multiple myeloma (NDMM) patients ineligible for or deferring autologous stem cell transplant (ASCT).
Data from the Phase 3 CEPHEUS study supports the submission, showing 60.9% of patients achieved minimal residual disease (MRD)-negativity with D-VRd, reducing the risk of progression or death by 43%. D-VRd demonstrated superior response rates and durability compared to the VRd regimen, with a complete response rate of 81.2%. Sustained MRD-negativity also favored D-VRd at 48.7% vs 26.3% for VRd.
The study enrolled 396 patients across 13 countries. Safety profiles for D-VRd were consistent with those of DARZALEX FASPRO and VRd.
FDA grants priority review to Innoviva's zoliflodacin for treatment of gonorrhea
AB Science secures Canadian patent for AB8939, completing global IP coverage for AML treatment
US FDA approves expanded indication for AbbVie's MAVYRET (glecaprevir/pibrentasvir) in acute HCV
Creo Medical secures FDA clearance for SpydrBlade Flex in US market
Psilera collaborates with Hesperos for PSIL-006 preclinical modelling for frontotemporal dementia
Myosin Therapeutics' MT-125 cleared by US FDA to initiate first-in-human trial in glioblastoma
Ondine's Steriwave proven effective against deadly Mucor fungus
AB Science receives EMA approval to extend Masivet shelf life to four years
Hemispherian's GLIX1 receives positive EU opinion for orphan designation in glioma
Arvinas and Pfizer submit FDA application for vepdegestrant in ESR1-mutated breast cancer
NRx Pharmaceuticals files ANDA for preservative-free IV ketamine
Innovent's IBI363 granted second breakthrough therapy designation in China
Implantica reports positive NICE guidance for RefluxStop procedure in UK hospitals